Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
10/2005
10/18/2005US6955625 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
10/18/2005CA2285633C Bacterial plasmids
10/18/2005CA2045012C Detection of poor metabolizers of drugs
10/13/2005WO2005095987A2 Salivary soluble cd44: a molecular marker for head and neck cancer
10/13/2005WO2005095985A1 Diagnostics and therapeutics for diseases associated with endothelin type b receptor-like protein 2 (etbr-lp-2)
10/13/2005WO2005095984A2 Diagnostics and therapeutics for diseases associated with g protein-coupled alpha 2a-adrenoceptor (adra2a)
10/13/2005WO2005095983A1 Diagnostics and therapeutics for diseases associated with protein kinase c, gamma (prkcg)
10/13/2005WO2005095964A2 Methods and compositions for the detection of cervical disease
10/13/2005WO2005095956A2 Diagnostics and therapeutics for diseases associated with megakaryocyte-associated tyrosine-protein kinase
10/13/2005WO2005095942A1 Method of analyzing biosample by laser ablation and apparatus therefor
10/13/2005WO2005095655A1 Quantitative assay for detection of newly synthesized rna in a cell-free system and identification of rna synthesis inhibitors
10/13/2005WO2005095654A1 Helicase-dependent amplification of circular nucleic acids
10/13/2005WO2005095653A2 Method for collecting purified cells
10/13/2005WO2005095652A2 Pnmt as a novel marker for progenitor cells
10/13/2005WO2005095651A2 Molecular markers of cisplatin resistance in cancer and uses thereof
10/13/2005WO2005095650A1 A method of genotyping blood cell antigens and kit suitable for genotyping blood cell antigens
10/13/2005WO2005095649A1 Dna chip for screening of peroxisome proliferator
10/13/2005WO2005095648A1 METHOD OF DETERMINING ALLELE OF BOVINE MAJOR HISTOCOMPATIBILITY GENE COMPLEX (BoLA) CLASS II DQA
10/13/2005WO2005095647A1 METHOD OF SCREENING siRNA
10/13/2005WO2005095646A2 Episomal expression system
10/13/2005WO2005095645A1 Sequential intracellular screening method
10/13/2005WO2005095644A2 Method for recognizing signatures in complex gene expression profiles
10/13/2005WO2005095643A1 Pdk4 as marker for ppardelta modulation
10/13/2005WO2005095642A1 Method of diagnosis of a predisposition to develop thrombotic disease and its uses
10/13/2005WO2005095641A1 Diagnostics and therapeutics for diseases associated with mitogen-activated protein kinase kinase kinase 11 (map3k11)
10/13/2005WO2005095640A1 Polymorphisms in nod2/card15 gene
10/13/2005WO2005095639A1 Method of multiquantification for cholesterol of low-density lipoprotein
10/13/2005WO2005095638A2 A kit for measuring the thrombin generation in a sample of a patient’s blood or plasma
10/13/2005WO2005095637A1 Diagnostics and therapeutics for diseases associated with mixed lineage kinase 4 beta (mlk4 beta)
10/13/2005WO2005095636A2 Methods for measuring enzyme activities in cells, blood, tumors and tissues
10/13/2005WO2005095635A1 Food borne pathogen sensor and method
10/13/2005WO2005095634A1 Method for the identification of a metabolic pathway family by means of positive selection
10/13/2005WO2005095633A1 A cell culture system for modelling serum amyloid a amyloidogenesis and identifying amyloid modulating compounds
10/13/2005WO2005095632A2 Methods for identifying proteins with starch phosphorylating enzymatic activity
10/13/2005WO2005095615A1 Assay for identifying compounds which affect stability of mrna
10/13/2005WO2005095612A1 Gene encoding guanine nucleotide exchange factor and gene product thereof
10/13/2005WO2005095608A1 Novel temperature regulated promoters and expression vectors from s.pombe
10/13/2005WO2005095605A1 Process for reducing the number of mismatches in double stranded polynucleotides
10/13/2005WO2005095604A1 Rf rp transgenic animal
10/13/2005WO2005095603A1 Detection instrument with the use of polynucleotides mapped on barley chromosome
10/13/2005WO2005095601A1 Method of evaluating drug-sensitivity by analyzing mu-opioid receptor gene
10/13/2005WO2005095599A1 Novel fluorescent protein and gene encoding the same
10/13/2005WO2005095587A1 Process for producing somatic stem cell differentiated from embryonic stem cell and use of the same
10/13/2005WO2005095577A1 Culture container, method of culturing chondrocytes and method of evaluating chondrocytes
10/13/2005WO2005095452A1 Calcium ion leakage inhibitors
10/13/2005WO2005094981A1 Cyclic pcr system
10/13/2005WO2005094913A1 Generation of nitric oxide in situ at substrate/blood interfaces and nitric oxide sensor for detecting nitrosothiols
10/13/2005WO2005094890A1 Composition for increasing body height
10/13/2005WO2005094887A1 sFRP EXPRESSION POTENTIATING AGENT
10/13/2005WO2005094886A1 Methods of inducing differentiation of regulatory t-cells and proliferating the same with gpi anchor protein agonist and medicinal composition therefor
10/13/2005WO2005094876A1 Diagnostics and therapeutics for diseases associated with p21 (cdkn1a)-activated kinase 2 (pak2)
10/13/2005WO2005094866A1 Adiponectin expression inducer and utilization of the same
10/13/2005WO2005094533A2 Trail-r as a negative regulator of innate immune cell responses
10/13/2005WO2005094532A2 Encoding and decoding reactions for determining target polynucleotides
10/13/2005WO2005094485A2 Drug screening
10/13/2005WO2005094453A2 Cospeptin, cosmedin and their uses
10/13/2005WO2005094421A2 Methods for concurrent identification and quantification of an unknown bioagent
10/13/2005WO2005094393A2 Methods and processes for attaching compounds to matrices
10/13/2005WO2005094381A2 Universal shotgun assay
10/13/2005WO2005094364A2 Iga antibody protein as a cytotoxic drug
10/13/2005WO2005094363A2 System, method and software arrangement for bi-allele haplotype phasing
10/13/2005WO2005094357A2 Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments
10/13/2005WO2005094356A2 Cngh0011 polynucleotides, polypeptides, antibodies, and compositions, and methods of production and use
10/13/2005WO2005094332A2 Biomarkers and methods for determining sensitivity to epidermal growth factor receptor modulators in non-small cell lung cancer
10/13/2005WO2005094324A2 Mixed cell diagnostic systems
10/13/2005WO2005094306A2 Identification of genes or polypeptides the expression of which correlates to fertility, ovarian function and/or fetal/newborn viability
10/13/2005WO2005094291A2 Computational selection of probes for localizing chromosome breakpoints
10/13/2005WO2005094288A2 Compositions and methods for determining epistatic relationships between hiv mutations that affect replication capacity
10/13/2005WO2005094279A2 Immortalized human tuberous sclerosis null angiomyolipoma cell and method of use thereof
10/13/2005WO2005094219A2 Unique chromosomal sequence of bacillus anthracis and methods of making and using thereof including real-time pcr assays
10/13/2005WO2005085851A3 Granulocyte subtype-selective receptors and ion channels and uses thereof
10/13/2005WO2005083426A3 Method, chip, device and integrated system for detection biological particles
10/13/2005WO2005083391A9 Method, chip, device and system for collection of biological particles
10/13/2005WO2005080420A3 Hyphal growth in fungi
10/13/2005WO2005078132A3 OLIGONUCLEOTIDE PROBES FOR DIAGNOSIS AND IDENTIFICATION OF THE DIFFERENT FORMS OF β-THALASSEMIA, METHODS AND DIAGNOSTIC KIT THEREOF
10/13/2005WO2005076925A3 Dutp based compositions for reducing primer-aggregate formation during nucleic acid amplification
10/13/2005WO2005073380A3 Regulated polymerase iii expression systems and related methods
10/13/2005WO2005071110A3 Improving polynucleotide ligation reactions
10/13/2005WO2005067648A3 Multiplex spatial profiling of gene expression
10/13/2005WO2005065328A3 Macrophage migration inhibitory factor (mif) as marker for urological inflammatory disease
10/13/2005WO2005058931A3 Methods and algorithms for identifying genomic regulatory sites
10/13/2005WO2005058479A3 Methods for synthesis of encoded libraries
10/13/2005WO2005042784A3 Device and method for high-throughput quantification of mrna from whole blood
10/13/2005WO2005042146A3 Apparatus and method for dispensing fluid, semi-solid and solid samples
10/13/2005WO2005038035A3 Methods for producing and using in vivo pseudotyped retroviruses
10/13/2005WO2005035715A3 Flanking dna sequences that control expression in the human genome
10/13/2005WO2005031002A3 Synthetic lethal screen using rna interference
10/13/2005WO2005027713A3 Compositions, splice variants and methods relating to colon specific genes and proteins
10/13/2005WO2005021717A3 Oligonucleotide sequestering agents and methods of use
10/13/2005WO2005019801A3 Method for rapid identification of molecules with functional activity towards biomolecular targets
10/13/2005WO2005019474A3 Human autism susceptibility gene and uses thereof
10/13/2005WO2005019469A3 Rna detection and quantitation
10/13/2005WO2005014788A3 Tssk4: a human testis specific serine/threonine kinase
10/13/2005WO2005010205A3 Biomarkers fo aggrecanase activity
10/13/2005WO2004113872A3 Covalent methods for immobilization of thiolated biomolecules on siliceous and metallic surfaces
10/13/2005WO2004109280A3 System and method for multidimensional evaluation of combinations of compositions
10/13/2005WO2004104176A3 Method for the identification of inhibitors of ornithine carbamoyltransferase, ketol-acid reductoisomerase, and fungal pathogenicity-conferring gene as antibiotics
10/13/2005WO2004097582A3 Computational methods and systems for multidimensional analysis
10/13/2005WO2004094661A3 Fancc, dad1, grim19 and hadhii marker genes of psoriasis
10/13/2005WO2004092327A3 Method of generating size standard nucleic acids
1 ... 1661 1662 1663 1664 1665 1666 1667 1668 1669 1670 1671 1672 1673 1674 1675 1676 1677 1678 1679 1680 1681 ... 3003